$RLFTF DD (opinion) by Brian A on Yh0 - Good even
Post# of 653
I just read an article appearing on the internet site, India dot tv, that the Hospital Chairperson of Ganga Ram Hospital in New Delhi, Dr. DS Rana, has said that they are considering dropping Remdesivir as a COVID therapeutic/treatment as, “...there is no evidence of its effectiveness in treating COVID patients.”
https://www.indiatvnews.com/news/india/remdes...nts-705500
While we already knew this, it further affirms the direction the NIH, FDA, EMA, actual hospital physicians in other countries, (et al) are taking with regard to Aviptadil’s/Zyesami’s future COVID indications.
I am truly of the opinion, as I know many of you are, that Aviptadil/Zyesami WILL become SOC for COVID, and MANY other respiratory ailments, in the US, Europe, their allied countries, and SO MANY other places around the globe.
It’s only a matter of time at this point, as Remdesivir continues to show limited, to no, efficacy against COVID.
We’re going “Prime Time” before you know it. Stay Long and Strong...it’s coming!
—Cheers to All—